IS4516A - Nýtt lyfjaform - Google Patents

Nýtt lyfjaform

Info

Publication number
IS4516A
IS4516A IS4516A IS4516A IS4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A
Authority
IS
Iceland
Prior art keywords
pharmaceutical preparation
human
relates
pharmaceutical form
present
Prior art date
Application number
IS4516A
Other languages
English (en)
Inventor
Gizurarson Sveinbjörn
Original Assignee
Gizurarson Sveinbjörn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gizurarson Sveinbjörn filed Critical Gizurarson Sveinbjörn
Priority to IS4516A priority Critical patent/IS4516A/is
Priority to AT98930657T priority patent/ATE307676T1/de
Priority to AU81022/98A priority patent/AU739893B2/en
Priority to PCT/DK1998/000297 priority patent/WO1999001229A1/en
Priority to DE69832070T priority patent/DE69832070T2/de
Priority to CA002298596A priority patent/CA2298596A1/en
Priority to ES98930657T priority patent/ES2255165T3/es
Priority to EP98930657A priority patent/EP0991479B1/en
Priority to DK98930657T priority patent/DK0991479T3/da
Priority to US09/446,931 priority patent/US6647980B1/en
Publication of IS4516A publication Critical patent/IS4516A/is

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS4516A 1997-07-01 1997-07-01 Nýtt lyfjaform IS4516A (is)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
US09/446,931 US6647980B1 (en) 1997-07-01 1998-07-01 Method for administration of active substances to the olfactory region
DE69832070T DE69832070T2 (de) 1997-07-01 1998-07-01 Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
AU81022/98A AU739893B2 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
AT98930657T ATE307676T1 (de) 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region
CA002298596A CA2298596A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
ES98930657T ES2255165T3 (es) 1997-07-01 1998-07-01 Unidad de envase de administracion para el suministro a la region olfativa.
EP98930657A EP0991479B1 (en) 1997-07-01 1998-07-01 An administration package unit for the delivery to the olfactory region
DK98930657T DK0991479T3 (da) 1997-07-01 1998-07-01 Pakningsenhed til indgivelse til lugteområdet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Publications (1)

Publication Number Publication Date
IS4516A true IS4516A (is) 1999-01-02

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Country Status (10)

Country Link
US (1) US6647980B1 (is)
EP (1) EP0991479B1 (is)
AT (1) ATE307676T1 (is)
AU (1) AU739893B2 (is)
CA (1) CA2298596A1 (is)
DE (1) DE69832070T2 (is)
DK (1) DK0991479T3 (is)
ES (1) ES2255165T3 (is)
IS (1) IS4516A (is)
WO (1) WO1999001229A1 (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
WO2002062416A1 (en) * 2001-02-08 2002-08-15 Nasaleze Limited Apparatus for dispensing powdered material
NZ534738A (en) * 2002-02-25 2007-01-26 Lyfjathroun Hf Absorption enhancing agent
JP2005524494A (ja) 2002-05-09 2005-08-18 グラクソ　グループ　リミテッド 流体分配装置
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
WO2005016275A2 (en) * 2003-08-05 2005-02-24 3M Innovative Properties Company Formulations containing an immune response modifier
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
BRPI0416128B8 (pt) 2003-11-03 2021-06-22 Glaxo Group Ltd dispositivo de dispensação de fluido
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
WO2007064657A1 (en) * 2005-11-29 2007-06-07 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
AU2006335994A1 (en) * 2006-01-19 2007-07-26 Optinose As Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) * 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
CN101662935A (zh) * 2007-05-04 2010-03-03 宝洁公司 抗微生物组合物、产品以及使用方法
ES2648196T3 (es) 2008-02-07 2017-12-29 The University Of Washington Dispositivo aerosol circunferencial
CN102427847A (zh) 2009-05-19 2012-04-25 爱德华N.·勒纳 将生物学活性物质增强多重递送至有机体并预防局部刺激的设备和方法
BR112013022249B8 (pt) 2011-03-03 2022-10-25 Impel Neuropharma Inc Dispositivo de distribuição de droga nasal
CN103619485B (zh) 2011-05-09 2017-08-08 英倍尔药业股份有限公司 用于鼻腔药物递送的喷嘴
WO2014179228A1 (en) 2013-04-28 2014-11-06 Impel Neuropharma Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
JP6753927B2 (ja) 2015-09-10 2020-09-09 インペル ニューロファーマ インコーポレイテッド 直列形経鼻送達デバイス
WO2019104192A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
WO2019104205A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with dip tube
AU2019205318B2 (en) 2018-01-05 2022-02-03 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
JP2021509677A (ja) 2018-01-05 2021-04-01 インペル ニューロファーマ インコーポレイテッド 精密嗅覚装置によるオランザピンの鼻孔間送達
CN112955134A (zh) 2018-07-19 2021-06-11 英倍尔药业股份有限公司 用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
KR20210109007A (ko) 2019-01-03 2021-09-03 임펠 뉴로파마 인코포레이티드 비강 약물 전달 장치
EP3969085A4 (en) 2019-05-17 2023-06-21 Impel Pharmaceuticals Inc. DISPOSABLE NASAL DELIVERY DEVICE
BR112022004497A2 (pt) * 2019-09-13 2022-05-31 Janssen Pharmaceuticals Inc Administração intranasal de escetamina
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
AU6909091A (en) 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) * 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) * 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
AU7669496A (en) 1995-11-03 1997-05-22 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
WO1999001229A1 (en) 1999-01-14
DK0991479T3 (da) 2006-03-13
EP0991479A1 (en) 2000-04-12
EP0991479B1 (en) 2005-10-26
ES2255165T3 (es) 2006-06-16
DE69832070D1 (de) 2005-12-01
DE69832070T2 (de) 2006-07-13
AU8102298A (en) 1999-01-25
AU739893B2 (en) 2001-10-25
CA2298596A1 (en) 1999-01-14
US6647980B1 (en) 2003-11-18
ATE307676T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
IS4516A (is) Nýtt lyfjaform
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
ATE196081T1 (de) L-dopa ester enthaltende zusammensetzung
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
DK0630230T3 (da) Farmaceutiske inhaleringspræparater
IL101056A (en) Composition for nasal treatment
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
MXPA02006518A (es) Aerosol de gota liquida de gamma -ifn y metodo.
TNSN01003A1 (fr) Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
MY117960A (en) A new salt
KR930019224A (ko) 유산 위험 치료제
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
RU97116821A (ru) Способ лечения респираторных заболеваний
EP1690531A3 (en) Dosage form and method for administering drug
TH66360A3 (th) องค์ประกอบและวิธีการเกี่ยวกับการรักษาโรคภูมิแพ้